You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR EPINEPHRINE BITARTRATE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for EPINEPHRINE BITARTRATE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02353676 ↗ Bupivacaine Supplementation For Postoperative Pain Control In Surgical Removal Of Mandibular Third Molars Unknown status Cosmozone Dental Clinic N/A 2015-01-01 Control of postoperative pain is a foremost goal in achieving a satisfactory postoperative recovery. Surgical removal of lower third molars is accompanied by postoperative pain that is at its peak in the first 12 hours. Our study evaluates if the use of 2% lidocaine hydrochloride for the surgical removal of lower third molars with a postoperative 0.5% bupivacaine supplementation would result in lesser postoperative pain and a decrease in ingestion of oral analgesics to control the pain when compared to a placebo.
NCT03672500 ↗ Perineal Local Infiltration Study Recruiting Sunnybrook Health Sciences Centre N/A 2018-09-14 The prevalence of birth canal lacerations is more than 70% of all deliveries in Canada. The repair of such lacerations is usually done using a pre-existing epidural analgesia. Once the analgesic effect of the epidural analgesia fades, the laceration may cause intolerable pain, and result in emotional stress, difficulties in ambulation and breastfeeding, and more. The research team hypothesis is that adding a locally injected analgesic, which will take effect once the epidural analgesia fades, may alleviate perineal pain, prevent such difficulties, and improve women's overall well-being and satisfaction. The proposed trial is a two-arm, single-masked, randomized trial. Women with a working epidural analgesia, and a laceration will be invited to participate. Women in the local anesthesia (LA) arm will get a LA injected to the laceration and women in the sham arm will get no injection. The differences in perineal pain between the groups will be evaluated at 6 hours after last epidural dose.
NCT05152901 ↗ Study of Inhaled Epinephrine and Intramuscular Epinephrine Administered to Healthy Adults Not yet recruiting Novotech (Australia) Pty Limited Phase 1 2022-01-23 This is a study to determine the relative bioavailability of inhaled epinephrine compared with 0.3mg epinephrine administered IM in healthy male and female participants.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for EPINEPHRINE BITARTRATE

Condition Name

Condition Name for EPINEPHRINE BITARTRATE
Intervention Trials
Anesthesia, Local 2
Anaphylactic Reaction 1
Episiotomy; Complications 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for EPINEPHRINE BITARTRATE
Intervention Trials
Anaphylaxis 1
Pain, Postoperative 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for EPINEPHRINE BITARTRATE

Trials by Country

Trials by Country for EPINEPHRINE BITARTRATE
Location Trials
Australia 1
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for EPINEPHRINE BITARTRATE

Clinical Trial Phase

Clinical Trial Phase for EPINEPHRINE BITARTRATE
Clinical Trial Phase Trials
Phase 1 1
N/A 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for EPINEPHRINE BITARTRATE
Clinical Trial Phase Trials
Unknown status 1
Not yet recruiting 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for EPINEPHRINE BITARTRATE

Sponsor Name

Sponsor Name for EPINEPHRINE BITARTRATE
Sponsor Trials
Cosmozone Dental Clinic 1
Sunnybrook Health Sciences Centre 1
Novotech (Australia) Pty Limited 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for EPINEPHRINE BITARTRATE
Sponsor Trials
Other 2
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.